Normann Steiner

18PUBLICATIONS
59CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 18, 2026
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

|Jan 21, 2026
Impact of anti-T-lymphocyte globulin dosing on graft versus host disease in matched sibling peripheral blood stem cell transplantation.

Radwan Massoud, Evgeny Klyuchnikov, Silke Heidenreich

|Oct 01, 2025
Sequential versus standard conditioning in untreated MDS patients with blasts undergoing allogeneic HSCT.

Radwan Massoud, Evgeny Klyuchnikov, Normann Steiner

|Nov 27, 2024
Beta-2-Microglobulin Maintains Overall Survival Prediction in Binet A Stage Chronic Lymphocytic Leukemia Patients with Compromised Kidney Function in Both Treatment Eras of Chemoimmunotherapy and Targeted Agents.

Jan-Paul Bohn, Valentina Stolzlechner, Georg Göbel

|Sep 20, 2024
Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete Remission.

Normann Steiner, Radwan Massoud, Johanna Richter

|Jun 14, 2024
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation.

Normann Steiner, Radwan Massoud, Evgeny Klyuchnikov

Pageof 3

Frequent Collaborators

4 joint publications

Nicolaus Kröger

3 joint publications

Francis Ayuk

3 joint publications

Christian Niederwieser

2 joint publications

Gesine Bug